Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
Por um escritor misterioso
Descrição
NIH-supported trial will test dalbavancin in hospitalized adults.
PDF) Efficacy of seven and fourteen days of antibiotic treatment
Adjunctive rifampicin for Staphylococcus aureus bacteraemia
Cureus An Update on Treatment Options for Methicillin-Resistant
IJMS, Free Full-Text
First patient dosed with dalbavancin in S. aureus bacteremia trial
Post-treatment outcomes of ceftriaxone versus antistaphylococcal
CAMERA2 – combination antibiotic therapy for methicillin-resistant
Methicillin-resistant Staphylococcus aureus: novel treatment
Full article: Investigational agents for the treatment of
Defining persistent Staphylococcus aureus bacteraemia: secondary
Antibiotics, Free Full-Text
Frontiers Futuristic Non-antibiotic Therapies to Combat
MRSA Infection: Guide to MRSA Spread, Treatment, and Prevention
Adjunctive rifampicin to reduce early mortality from
Antibiotics, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
